BE873102A - Composes de l'ether aminophenylique utilises pour le traitement de l'arteriosclerose - Google Patents

Composes de l'ether aminophenylique utilises pour le traitement de l'arteriosclerose

Info

Publication number
BE873102A
BE873102A BE192584A BE192584A BE873102A BE 873102 A BE873102 A BE 873102A BE 192584 A BE192584 A BE 192584A BE 192584 A BE192584 A BE 192584A BE 873102 A BE873102 A BE 873102A
Authority
BE
Belgium
Prior art keywords
emi
group
lower alkyl
compound
substituted
Prior art date
Application number
BE192584A
Other languages
English (en)
French (fr)
Inventor
J Matsumoto
T Kojima
I Ohata
N Sato
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of BE873102A publication Critical patent/BE873102A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
BE192584A 1977-12-29 1978-12-27 Composes de l'ether aminophenylique utilises pour le traitement de l'arteriosclerose BE873102A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15809977A JPS5492926A (en) 1977-12-29 1977-12-29 Compound of aminophenyl ether and its preparation

Publications (1)

Publication Number Publication Date
BE873102A true BE873102A (fr) 1979-06-27

Family

ID=15664272

Family Applications (1)

Application Number Title Priority Date Filing Date
BE192584A BE873102A (fr) 1977-12-29 1978-12-27 Composes de l'ether aminophenylique utilises pour le traitement de l'arteriosclerose

Country Status (2)

Country Link
JP (1) JPS5492926A (ko)
BE (1) BE873102A (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006264649A1 (en) * 2005-06-30 2007-01-11 Prosidion Limited GPCR agonists

Also Published As

Publication number Publication date
JPS5492926A (en) 1979-07-23
JPS6129330B2 (ko) 1986-07-05

Similar Documents

Publication Publication Date Title
EP0371876A1 (fr) Composés isoxazoles et isoxazolines à activité anticonvulsivante, procédé de préparation et compositions thérapeutiques les contenant
CH651561A5 (fr) Derives des nor-tropane et granatane et leur procede de preparation.
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
CH619932A5 (ko)
FR2599739A1 (fr) Acides biphenyl hydroxamiques a action therapeutique
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
EP0360685A1 (fr) "[(diarylméthoxy) alcoyl] - 1 pyrrolidines et piperidines, procédés de préparation et médicaments les contenant"
EP0376850B1 (fr) Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant
FR2487827A1 (fr) Nouveaux derives de la phenetylamine et procede pour leur production
CH643243A5 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs.
BE873102A (fr) Composes de l'ether aminophenylique utilises pour le traitement de l'arteriosclerose
EP0015171A1 (fr) Dérivés condensés de pyrrolidine ou de pipéridine, leur procédé de préparation et composition les contenant
CA1076117A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
EP0105881B1 (fr) Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
EP0347305B1 (fr) [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif
CH639374A5 (fr) N-(4-pyrazolidinyl)-benzamides, presentant notamment des proprietes antiemetiques et de vidage gastrique.
FR2690917A1 (fr) Aminoesters, leur procédé de préparation et leur application en thérapeutique.
EP0054593B1 (fr) Dérivés du pyrrole protecteurs du myocarde ayant une activité antiarythmique et antiagrégante plaquettaire, leur procédé de préparation et les médicaments en contenant
CA1095039A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
CH392508A (fr) Procédé de préparation d'esters de 3-phényl-3-pyrrolidinols
CH401943A (fr) Procédé pour la préparation d'alcoxy-triphényl-méthanols substitués basiques
CH629771A5 (fr) N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl)benzamides.
FR2524881A1 (fr) Nouvelles indole-alkylene-amines substituees, leur preparation et leur utilisation comme medicaments
BE834086A (fr) Dicarboximides tricycliques